Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug use review

Warholak-Juarez T, Rupp MT, Salazar TA, et al. 2000. Effect of patient information on the quality of pharmacists drug use review decisions. J Am Pharm Assoc 40 500. [Pg.114]

The definition of clinical pharmacy services may vary considerably under the generalist model. Services may consist of departmentally defined drug monitoring, collection of data for drug-use reviews, and target drug class screening. Pharmacists provide clinical ser-... [Pg.597]

Staler M. Drug use review operational definitions. Am.. Hosp. Pharm. 1978 33 225-230. [Pg.203]

Kane, M.P. Briceland, L.L. Garris, R.E. Favreau, B.N. Drug use review program for concurrent histamine H2... [Pg.324]

Medicaid program Drug use review program and electronic claims management system for outpatient drug claims. Fed. Regist. 1992, 57, 49397-49412 (Nov. 2). [Pg.548]

Dzierba, S. Limited resource approach to drug-use review. Top Hosp. Pharm. Manage. 1991, 11 (1), 87-91. [Pg.549]

Rupp, M.T. Establishing realistic performance standards for community pharmacists drug-use—review activities in managed care contracts. Am. J. Health-Syst. Pharm. 1999, 56, 566-567. [Pg.834]

Fritz, D, L., Drug Use Review Principles Adopted by Key Organizations, Journal of the American Association of Preferred Provider Organizations l(4) 22-26, 1991. [Pg.329]

Educating the Patient and Family If lypressin or desmopressin is to be used in the form of a nasal spray or is to be instilled intranasally usingthe nasal tube delivery system, the nurse demonstrates the technique of instillation (see Fhtient and Family Teaching Checklist Self-Adnrinistering Nasal Vasopressin). The nurse includes illustrated patient instructions with the drug and reviews them with the patient. If possible, the nurse lias the patient demonstrate the technique of administration. The nurse should discuss the need to take the drug only as directed by the primary health care provider. The patient should not increase the dosage (ie, the number or frequency of sprays) unless advised to do so by the primary health care provider. [Pg.521]

Brown, D.H. and Smith, W.E. (1980) The chemistry of the gold drugs used in the treatment of rheumatoid arthritis. Chemical Society Reviews, 9, 217-239. [Pg.314]

Obtain a thorough history of the patient s prescription, nonprescription, and natural product use. Review for potential drug-drug and drug-glaucoma interactions. [Pg.922]

J. E. Finchman, Over-the-counter drug use and misuse by the ambulatory elderly A review of the literature, J. Geriatr. Drug Ther., 1, 3 (1986). [Pg.691]

Polypharmacy is often a consequence of the cascade of problems. A literature review found that polypharmacy continues to increase and is a known risk factor for important morbidity and mortality (Hajjar et al. 2007). The reviewers states that many studies have found that various numbers of medications are associated with negative health outcomes, but more research is needed to further delineate the consequences associated with unnecessary drug use in elderly patients. Health care professionals should be aware of the risks and fully evaluate all medications at each patient visit to prevent polypharmacy from occurring . [Pg.98]


See other pages where Drug use review is mentioned: [Pg.34]    [Pg.495]    [Pg.509]    [Pg.509]    [Pg.196]    [Pg.196]    [Pg.196]    [Pg.416]    [Pg.515]    [Pg.548]    [Pg.548]    [Pg.108]    [Pg.34]    [Pg.495]    [Pg.509]    [Pg.509]    [Pg.196]    [Pg.196]    [Pg.196]    [Pg.416]    [Pg.515]    [Pg.548]    [Pg.548]    [Pg.108]    [Pg.161]    [Pg.343]    [Pg.243]    [Pg.668]    [Pg.271]    [Pg.139]    [Pg.723]    [Pg.1299]    [Pg.423]    [Pg.635]    [Pg.689]    [Pg.803]    [Pg.82]    [Pg.133]    [Pg.169]    [Pg.221]    [Pg.450]    [Pg.54]    [Pg.81]    [Pg.3]    [Pg.122]    [Pg.181]    [Pg.46]    [Pg.126]   
See also in sourсe #XX -- [ Pg.196 ]




SEARCH



Drugs, reviews

© 2024 chempedia.info